Search

everythinglearnresearchcommunity

for

Search:↓

Gushen Shengfa pills and Wuling capsules are more effective for hair growth and sleep quality than the control treatment.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Finasteride reduces some inflammation in BPH but not all.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Fzd2 is important for skin and hair development through various signaling ways.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

People with alopecia areata are more likely to have other immune-related conditions.

Regulatory T cells are essential for normal and improved wound healing in mice.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The study suggests that hypothyroidism may cause alopecia areata.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.